heltzen investor press clippings video MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic Sep 18, 2025 8:16:00 AM
heltzen press release investor press clippings Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything' May 16, 2025 9:09:00 AM
heltzen investor press clippings video Slack Capital: EXOZ investment report and CEO interview May 13, 2025 5:30:00 PM
heltzen investor press clippings video Fox Business: Interview with CEO Michael Heltzen Mar 3, 2025 11:00:00 AM
heltzen investor video Looking at the rest of 2025 - part 4 of a fireside chat about Invizyne Feb 11, 2025 6:00:00 AM
heltzen investor video ARCHIVE ARCHIVE: Go To Market Strategy - part 3 of a fireside chat about Invizyne Jan 15, 2025 12:00:00 AM
heltzen investor video ARCHIVE ARCHIVE: Using AI for Enzyme Engineering - Part 2 of a Fireside Chat About Invizyne Jan 7, 2025 12:00:00 AM
heltzen investor video ARCHIVE ARCHIVE: Looking back at 2024 - part 1 of a fireside chat about Invizyne Dec 31, 2024 12:00:00 AM
.png?width=1024&height=1024&name=ExoZymes%20-%20Introduction%20(1).png)
.png?width=1024&height=1024&name=Screenshot%202025-01-13%20at%2023.31.19%20(2).png)
.png?width=1024&height=1024&name=Screenshot%202025-01-13%20at%2023.31.07%20(2).png)
.png?width=1024&height=1024&name=Screenshot%202024-12-31%20at%2001.05.49%20(2).png)
.png?width=1024&height=1024&name=Screenshot%202024-12-30%20at%2023.38.58%20(2).png)